Repression of the stress granule protein G3BP2 inhibits immune checkpoint molecule PD‐L1
Autor: | Igor Garkavtsev, Anna M. Krichevsky, Changli Yue, Yanhong Zhang |
---|---|
Rok vydání: | 2022 |
Předmět: |
0301 basic medicine
Cancer Research biology Chemistry medicine.medical_treatment Cancer Immunosuppression General Medicine Immunotherapy medicine.disease Immune checkpoint 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Stress granule Oncology 030220 oncology & carcinogenesis PD-L1 Cancer cell Genetics Cancer research medicine biology.protein Molecular Medicine Cytotoxic T cell |
Zdroj: | Molecular Oncology. |
ISSN: | 1878-0261 1574-7891 |
DOI: | 10.1002/1878-0261.12915 |
Popis: | Mounting evidence suggests that cancer stemness and immunosuppression are related, but the underlying mechanisms behind these are not clear. We previously reported that the stress granule-associated protein G3BP2 is involved in the regulation of tumor-initiating (stem) cells. In this study, we show that this protein also upregulates the immune checkpoint molecule PD-L1 under conditions of stress in breast and glioblastoma cancer cells, revealing a previously unknown connection between stemness programs, stress responses, and immune checkpoint control. We also identified a significant correlation between G3BP2 and PD-L1 co-expression in tumor tissues from cancer patients. To assess the targetability of G3BP2, we employed a small molecule (C108) that binds G3BP2 and interferes with the stress response. Tumors treated with C108 had increased CD8 T-cell proliferation and infiltration. Moreover, treatment of breast tumor-bearing mice with C108 resulted in a significant survival benefit and long-term cures. Cancer cells treated with C108 or cancer cells with genetically repressed G3BP2 had decreased PD-L1 expression due to enhanced mRNA degradation. Our study provides a compelling mechanism linking stress granule formation and immune checkpoint program of cancer, suggesting this link may provide new opportunities for improving anticancer immunotherapy. |
Databáze: | OpenAIRE |
Externí odkaz: |